Donepezil Tablet 23 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.
MFDS item code 202103130 · Approved 2021.04.15
Treatment of symptoms of moderate to severe Alzheimer-type dementia
This medication is used to treat symptoms of moderate to severe Alzheimer’s type dementia.
This medicine is taken once daily in the evening immediately before bedtime and may be administered with or without food. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Do not split, crush, or chew this medicine, as this may increase the rate of absorption. The recommended initial dose of donepezil hydrochloride is 5mg once daily. This medicine reaches steady state 15 days after administration, and the incidence of adverse reactions may be affected by the rate of dose escalation; therefore, administer 5mg for 4 ~ 6 weeks. After assessing the clinical response during this period, the dose may be increased to 10mg. When increasing the dose to 10mg daily, administer with caution for gastrointestinal adverse reactions. A dose of 23mg once daily may be administered to patients who have taken 10mg once daily for at least 3 months.
This medicine contains Donepezil Hydrochloride Hydrate as its main ingredient, and is primarily used to alleviate symptoms of Alzheimer’s type dementia. First, this medication should not be taken by individuals who are allergic to Donepezil Hydrochloride, piperidine derivatives, or any of the ingredients in this medicine. Additionally, it is advisable for women who are pregnant or may become pregnant and those who are breastfeeding to avoid using this medication. This medication contains lactose, so individuals with genetic issues such as galactose intolerance, lactose enzyme deficiency, or glucose-galactose malabsorption should not take it. Individuals with heart disease or arrhythmias should use this medication cautiously as it may slow the heart rate or cause arrhythmias. Those taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should carefully monitor their gastrointestinal status. Individuals with asthma or obstructive pulmonary disease should be cautious as bronchoconstriction or increased mucous secretion may occur. Those with extrapyramidal disorders such as Parkinson's disease should be careful, as symptoms may worsen. This medication contains Yellow No. 4 (tartrazine), and individuals allergic to this substance should also exercise caution. Side effects may include heart-related issues, gastrointestinal bleeding, liver dysfunction, cerebrovascular problems, movement disorders, neuroleptic malignant syndrome, and rhabdomyolysis; if any unusual symptoms appear, immediate consultation with a physician is necessary. Moreover, various symptoms such as nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, headache, and fatigue may occur, although these symptoms are generally mild or transient. This medication is not approved for use in other types of dementia or memory disorders other than Alzheimer's type dementia, and treatment should be conducted under the supervision of an experienced physician. Individuals with heart disease or electrolyte imbalances may require electrocardiogram testing, and this medication may increase gastric acid secretion, potentially worsening peptic ulcers, so gastrointestinal status should be closely monitored. As a cholinesterase inhibitor, this medication may cause bronchoconstriction, so those with respiratory diseases should exercise caution. Women who are pregnant or breastfeeding are advised not to take this medication; if it must be taken, breastfeeding should be discontinued. Safety for pediatric use has not been established, so it should not be used in children. This medication may affect liver and kidney function, so regular testing may be necessary. In cases of overdose, symptoms such as nausea, vomiting, decreased heart rate, respiratory suppression, and seizures may occur, and immediate medical attention is required. This medication may interact with some drugs, so it is essential to consult a physician or pharmacist if taking other medications.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. Proper storage can help maintain the medication's efficacy for a longer duration.
Red, biconvex, round film-coated tablets
Bottle - 30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.